160 related articles for article (PubMed ID: 33318666)
1. The relationship between body mass index and N-terminal pro-B-type natriuretic peptide in community-acquired pneumonia.
Lee JS; Ko SH; Lee J; Jeong KY
Eur J Clin Nutr; 2021 Jul; 75(7):1088-1098. PubMed ID: 33318666
[TBL] [Abstract][Full Text] [Related]
2. Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
Bhatt AS; Cooper LB; Ambrosy AP; Clare RM; Coles A; Joyce E; Krishnamoorthy A; Butler J; Felker GM; Ezekowitz JA; Armstrong PW; Hernandez AF; O'Connor CM; Mentz RJ
J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29431103
[TBL] [Abstract][Full Text] [Related]
3. Influence of Body Mass Index on the Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Level in Chinese Patients with Heart Failure.
Tian L; Li X; Zhang J; Tian X; Wan X; Yao D; Luo B; Huang Q; Deng Y; Xiang W
Int Heart J; 2024; 65(1):47-54. PubMed ID: 38296579
[TBL] [Abstract][Full Text] [Related]
4. Do N-terminal pro-brain natriuretic peptide levels determine the prognosis of community acquired pneumonia?
Akpınar EE; Hoşgün D; Akpınar S; Ateş C; Baha A; Gülensoy ES; Ogan N
J Bras Pneumol; 2019 Aug; 45(4):e20180417. PubMed ID: 31411279
[TBL] [Abstract][Full Text] [Related]
5. NT-proBNP for Risk Prediction in Heart Failure: Identification of Optimal Cutoffs Across Body Mass Index Categories.
Vergaro G; Gentile F; Meems LMG; Aimo A; Januzzi JL; Richards AM; Lam CSP; Latini R; Staszewsky L; Anand IS; Cohn JN; Ueland T; Gullestad L; Aukrust P; Brunner-La Rocca HP; Bayes-Genis A; Lupón J; Yoshihisa A; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Gamble GD; Ling LH; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Troughton R; Doughty RN; Devlin G; Lund M; Giannoni A; Passino C; de Boer RA; Emdin M
JACC Heart Fail; 2021 Sep; 9(9):653-663. PubMed ID: 34246607
[TBL] [Abstract][Full Text] [Related]
6. Clinical Impact of N-Terminal Prohormone of Brain Natriuretic Peptide on Patients Hospitalized with Community-Acquired Pneumonia.
Seo H; Cha SI; Shin KM; Lim JK; Choi SH; Lee YH; Yoo SS; Lee SY; Lee J; Kim CH; Park JY
Am J Med Sci; 2020 Oct; 360(4):383-391. PubMed ID: 32690276
[TBL] [Abstract][Full Text] [Related]
7. Direct comparison of three natriuretic peptides for prediction of short- and long-term mortality in patients with community-acquired pneumonia.
Nowak A; Breidthardt T; Christ-Crain M; Bingisser R; Meune C; Tanglay Y; Heinisch C; Reiter M; Drexler B; Arenja N; Twerenbold R; Stolz D; Tamm M; Müller B; Müller C
Chest; 2012 Apr; 141(4):974-982. PubMed ID: 22135381
[TBL] [Abstract][Full Text] [Related]
8. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
[TBL] [Abstract][Full Text] [Related]
9. Impact of increased body mass index on accuracy of B-type natriuretic peptide (BNP) and N-terminal proBNP for diagnosis of decompensated heart failure and prediction of all-cause mortality.
Christenson RH; Azzazy HM; Duh SH; Maynard S; Seliger SL; Defilippi CR
Clin Chem; 2010 Apr; 56(4):633-41. PubMed ID: 20167699
[TBL] [Abstract][Full Text] [Related]
10. Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea.
Bayes-Genis A; Lloyd-Jones DM; van Kimmenade RR; Lainchbury JG; Richards AM; Ordoñez-Llanos J; Santaló M; Pinto YM; Januzzi JL
Arch Intern Med; 2007 Feb; 167(4):400-7. PubMed ID: 17325303
[TBL] [Abstract][Full Text] [Related]
11. Sex-specific associations of obesity and N-terminal pro-B-type natriuretic peptide levels in the general population.
Suthahar N; Meijers WC; Ho JE; Gansevoort RT; Voors AA; van der Meer P; Bakker SJL; Heymans S; van Empel V; Schroen B; van der Harst P; van Veldhuisen DJ; de Boer RA
Eur J Heart Fail; 2018 Aug; 20(8):1205-1214. PubMed ID: 29855124
[TBL] [Abstract][Full Text] [Related]
12. Natriuretic peptides, body mass index and heart failure risk: Pooled analyses of SAVOR-TIMI 53, DECLARE-TIMI 58 and CAMELLIA-TIMI 61.
Patel SM; Morrow DA; Bellavia A; Berg DD; Bhatt DL; Jarolim P; Leiter LA; McGuire DK; Raz I; Steg PG; Wilding JPH; Sabatine MS; Wiviott SD; Braunwald E; Scirica BM; Bohula EA
Eur J Heart Fail; 2024 Feb; 26(2):260-269. PubMed ID: 38131261
[TBL] [Abstract][Full Text] [Related]
13. Impact of body mass index on plasma N-terminal ProB-type natriuretic peptides in Chinese atrial fibrillation patients without heart failure.
Zheng LH; Wu LM; Yao Y; Chen WS; Bao JR; Huang W; Shi R; Zhang KJ; Zhang S
PLoS One; 2014; 9(8):e105249. PubMed ID: 25144363
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers of cardiac dysfunction and mortality from community-acquired pneumonia in adults.
Chang CL; Mills GD; Karalus NC; Jennings LC; Laing R; Murdoch DR; Chambers ST; Vettise D; Tuffery CM; Hancox RJ
PLoS One; 2013; 8(5):e62612. PubMed ID: 23667500
[TBL] [Abstract][Full Text] [Related]
15. Highest Obesity Category Associated With Largest Decrease in N-Terminal Pro-B-Type Natriuretic Peptide in Patients Hospitalized With Heart Failure With Preserved Ejection Fraction.
Vaishnav J; Chasler JE; Lee YJ; Ndumele CE; Hu JR; Schulman SP; Russell SD; Sharma K
J Am Heart Assoc; 2020 Aug; 9(15):e015738. PubMed ID: 32750299
[TBL] [Abstract][Full Text] [Related]
16. Relationship between body mass index, cardiovascular biomarkers and incident heart failure.
Suthahar N; Meems LMG; Groothof D; Bakker SJL; Gansevoort RT; van Veldhuisen DJ; de Boer RA
Eur J Heart Fail; 2021 Mar; 23(3):396-402. PubMed ID: 33443299
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction].
Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276
[No Abstract] [Full Text] [Related]
18. N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study.
Ndumele CE; Matsushita K; Sang Y; Lazo M; Agarwal SK; Nambi V; Deswal A; Blumenthal RS; Ballantyne CM; Coresh J; Selvin E
Circulation; 2016 Feb; 133(7):631-8. PubMed ID: 26746175
[TBL] [Abstract][Full Text] [Related]
19. Association of N-terminal pro-B-type natriuretic peptide levels and mortality risk in acute myocardial infarction across body mass index categories: an observational cohort study.
Wang M; Cao N; Zhou L; Su W; Chen H; Li H
Diabetol Metab Syndr; 2023 Oct; 15(1):192. PubMed ID: 37798776
[TBL] [Abstract][Full Text] [Related]
20. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
